This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Bajaj Healthcare board meeting on Oct 17 to approve Q2 FY27 results
BAJAJHCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.7 pts more than Nifty Microcap 250 and 2.7 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Bajaj Healthcare has informed stock exchanges that its Board of Directors will meet on October 17, 2026 to consider and approve the un-audited financial results for the quarter and half year ended September 30, 2026 (Q2 FY27). The trading window for insiders and designated persons has been closed from October 1, 2026 until 48 hours after the results are declared.
Routine pre-results intimation; actual earnings to be disclosed on Oct 17, 2026.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹175.9 Cr | ₹147.9 Cr | +18.9% |
| Operating profit | ₹17.58 Cr | ₹14.31 Cr | +22.9% |
| Profit after tax | ₹14.09 Cr | ₹11.11 Cr | +26.9% |
| EBITDA margin | 17.7% | 18.2% | −0.5 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.